Why Don't You Diversify Your Portfolio With Some European Blue Chips?
Gold Finder - at Seeking Alpha - Fri Jan 23, 9:50AM CST
UN: 42.28 (-0.30), HSBC: 46.13 (-0.01), GOOG: 549.01 (+6.08), T: 34.66 (+0.05), BRK.A: 222,555.00 (-1,905.00), NVS: 102.20 (-0.17)
Medical Speciality Bags Market - 2014-2020 Global Industry Analysis
M2 - Tue Dec 16, 4:59AM CST
Research and Markets (http://www.researchandmarkets.com/research/xx3v47/medical) has announced the addition of the "Medical Speciality Bags Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. Medical speciality bags provide assistance in curbing disorders that originate from medical conditions such as bowel incontinence, bile leakage and others. Growth of the medical speciality bags market is driven by key factors such as global aging population, less stringent FDA regulations for class I medical devices, increasing global healthcare-related consumer spending, and consumer awareness programs and government initiatives. Based on product types, the medical speciality bags market has been divided into eleven segments: anesthesia breathing bags, bile collection bags, blood bags, continuous ambulatory peritoneal dialysis (CAPD) bags, enema bags, enteral feeding bags, intravenous fluid bags, ostomy collection bags, resuscitation bags, urinary collection bags, and others (cadaver bags and ice bags). Ostomy collection bags held the highest share in 2013 owing to the rising prevalence of chronic diseases such as Crohn's disease and Ulcerative Colitis, aging population, increase in the number of customer awareness programs and surging disposable income of consumers. According to the CDC, approximately 1 million to 1.3 million people suffer from inflammatory bowel diseases (IBD) in the U.S. each year. High prevalence of IBD coupled with rising awareness has helped ostomy collection bags to hold the largest share of the medical specialty bags market in 2013. Scope of the Report - Anesthesia Breathing Bags - Bile Collection Bags - Blood Bags - Continuous Ambulatory Peritoneal Dialysis (CAPD) Bags - Enema Bags - Enteral Feeding Bags - Intravenous Fluid/Infusion bags - Ostomy Collection Bags - - Single-use Ostomy Bags - - Multi-use Ostomy Bags - Resuscitation Bags - - Reusable Resuscitation Bags - - Disposable Resuscitation Bags - Urinary Collection Bags - Others (Ice Bags, Cadaver Bags) Companies Mentioned - B. Braun Melsungen AG - Baxter International Inc. - Coloplast A/S - ConvaTec Inc. - Fresenius SE & Co. KGaA - Hollister Incorporated - Macopharma SA - Medline Industries Inc. - Nolato AB - Smiths Medical - Terumo Corporation For more information visit http://www.researchandmarkets.com/research/xx3v47/medical
BAX: 70.39 (+0.31)
Dialysis Products and Services Market Report - Global Industry Analysis 2014-2020
M2 - Thu Nov 27, 2:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/55wbqr/dialysis_products) has announced the addition of the "Dialysis Products and Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. This report studies the global market for dialysis products and services from three major perspectives: product type, service type and geography. The stakeholders of this study include existing companies manufacturing dialysis products or providing dialysis services to the patients and new entrants who are planning to invest in this market. The report comprises of an executive summary section that provides a snapshot of the market with succinct information about market size and growth of different product segments, services, market share and geographic analysis of the global dialysis products and services market. The market overview section illustrates about the global market dynamics and trends comprising of drivers, restraints and opportunities that influence the current and future status of the dialysis products and services market. Several other factors such as market share analysis by major market players and Porter's five force analysis are also included in this report providing a thorough analysis about the competitive scenario in the global dialysis products and services market. Further, the market overview section also includes regulatory scenario of dialysis products and services market at global scale along with the announcements and guidelines by important bodies such as Food and Drug Administration (FDA) and Association for the Advancement of Medical Instrumentation (AAMI). These factors are explained thoroughly to help the market players in planning their strategies which will help them in expanding their presence and in strengthening their position in the global market. Report Scope Dialysis Products and Services Market, by Product type: - Hemodialysis - HD Machines - Dialyzers - HD Access Products/Catheters - Bloodlines - HD Concentrates/Dialysate - Others (Water Treatment System, Fistula Needles) - Peritoneal Dialysis - Concentrates/Dialysate - PD Machines - PD Catheters - PD Transfer Sets Dialysis Products and Services Market, by Type of Services: - In-center Dialysis - Home Dialysis Companies Mentioned - Asahi Kasei Corporation - B. Braun Melsungen AG - Baxter International, Inc. - C. R. Bard, Inc. - Cantel Medical Corporation - Covidien plc - DaVita Healthcare Partners, Inc. - Fresenius SE & Co. KGaA - Kawasumi Laboratories, Inc. - Medical Components, Inc. - Nikkiso Co., Ltd. - Nipro Corporation - NxStage Medical, Inc. - Rockwell Medical Technologies, Inc. For more information visit http://www.researchandmarkets.com/research/55...s_products
NXTM: 17.56 (-0.05), BAX: 70.39 (+0.31), RMTI: 11.17 (+0.15), CMN: 44.28 (+1.09)
Research Report on Hemodialysis Industry in China, 2014-2018
M2 - Wed Sep 17, 8:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wn2tjb/research_report) has announced the addition of the "Research Report on Hemodialysis Industry in China, 2014-2018" report to their offering. The market size of Chinese hemodialysis market exceeded CNY 20 billion in China in 2013 with the annual growth rate of 20%- 30%. Instruments, drugs and services are three major factors of the hemodialysis market, also the three entry points of the industry chain. Hemodialysis (also HD) is one of the replace therapy for patients with acute and chronic renal failure. There are globally 2.2 million uremia patients (end stage renal disease, ESRD) receiving dialysis treatment, including over 89% of them receiving hemodialysis. As the cost of hemodialysis is high, most dialysis patients are concentrated in developed regions like Europe and the U.S. The dialysis patients are fewer in developing countries but increases rapidly. In recent years, the growth rate of dialysis patients in China, India and Brazil remains above 15%, much higher than 3%- 5% in Europe and the U.S. Meanwhile, the proportion of ESRD patients that receive dialysis treatment is only 10%- 20% in developing countries, much lower than 80% in Europe and the U.S.A. By 2020, the global ESRD patients receiving hemodialysis treatment will reach 4.2 million while that in China will surpass 1 million. The market size of Chinese hemodialysis market is expected to exceed CNY 70 billion in China by 2020 with the CAGR above 20%. Meanwhile, the market size of auxiliary drugs will exceed CNY 60 billion. Key Topics Covered: 1 Overview of Hemodialysis Industry 2 Analysis of Global Hemodialysis Market, 2011-2014 3 Development Environment of China Hemodialysis Industry, 2011-2018 4 Operation Status of China Hemodialysis Industry, 2011-2014 5 Competition Status of China Hemodialysis Industry, 2011-2014 6 Analysis of Import and Export of Hemodialysis Equipment and Drugs in China, 2011-2014 7 Key Enterprises in China Hemodialysis Market, 2011-2014 8 Prospect of China Hemodialysis Industry Companies Mentioned - Asahi Kasei Corporation - Bain Medical Equipment (Guangzhou) Co., Ltd. - Baxter International - Fresenius SE & Co. KGaA - Guangdong Biolight Meditech Co., Ltd. - Huaren Pharmaceutical Co., Ltd. - Jihua Medical Apparatus and Instruments Co., Ltd. - Nipro Co.,Ltd. - Sichuan Kelun Pharmaceutical Co., Ltd. - Weigao Group For more information visit http://www.researchandmarkets.com/research/wn...rch_report
BAX: 70.39 (+0.31)
Global Dialysis Products and Services (Hemodialysis Products, Peritoneal Dialysis Products
M2 - Thu Sep 11, 5:50AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c8vw2r/dialysis_products) has announced the addition of the "Dialysis Products and Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. According to the National Institutes of Health, the worldwide number of patients with chronic kidney disease is rising rapidly and is expected to rise by approximately 5% to 8% annually. Increasing prevalence of diabetes and hypertension are the two primary causes of end stage renal disease in major developing countries like China, Brazil and India and is also contributing to the growth of overall dialysis products and services market. According to the American Kidney Fund, diabetes and hypertension are responsible for 38.4% and 25% of all cases of kidney failures, respectively. Similarly, increasing geriatric population and low preference by patients above 65 years of age to opt for kidney transplant is also driving the growth of dialysis products and services market. According to the Australian Institute of Health and Welfare, the proportion of people opting for kidney transplantation decreases with age. Moreover, increasing awareness about peritoneal dialysis is expected to boost the growth of the market in the near future. The global dialysis products and services market is segmented by type of procedures and type of services. The procedures market is further segmented into hemodialysis and peritoneal dialysis. Further, the hemodialysis segment (HD) is classified into HD machine, dialyzer, access products/catheters, bloodlines, concentrates and others, which include water treatment systems and fistula needles. Hemodialysis, being the oldest and most preferred technique for dialysis procedure, Hemodialysis machines captures the largest share, of the total market in 2013. The segment is expected to lead the market during the forecast period from 2014 to 2020. Similarly, peritoneal dialysis (PD) segment is classified into concentrates/dialysate, PD machines, catheters, and transfer sets. Among these, the PD concentrates/dialysate segment is accounted for largest market share in 2013 and is expected to grow at an attractive higher growth rate during the forecast period from 2014 to 2020. The major factors responsible for the significant growth of this segment are increase in the number of patients preferring peritoneal dialysis, and rising demand of patients to be dialyzed overnight with the aid of peritoneal dialysis. Dialysis Products and Services Market, by Product type: Hemodialysis - HD Machines - Dialyzers - HD Access Products/Catheters - Bloodlines - HD Concentrates/Dialysate - Others (Water Treatment System, Fistula Needles) Peritoneal Dialysis - Concentrates/Dialysate - PD Machines - PD Catheters - PD Transfer Sets Dialysis Products and Services Market, by Type of Services: - In-center Dialysis - Home Dialysis Companies Mentioned - Asahi Kasei Corporation - B. Braun Melsungen AG - Baxter International, Inc. - C. R. Bard, Inc. - Cantel Medical Corporation - Covidien plc - DaVita Healthcare Partners, Inc. - Fresenius SE & Co. KGaA - Kawasumi Laboratories, Inc. - Medical Components, Inc. - Nikkiso Co., Ltd. - Nipro Corporation - NxStage Medical, Inc. - Rockwell Medical Technologies, Inc. For more information visit http://www.researchandmarkets.com/research/c8...s_products
NXTM: 17.56 (-0.05), BAX: 70.39 (+0.31), RMTI: 11.17 (+0.15), CMN: 44.28 (+1.09)
DuPont appoints Ulf M. "Mark" Schneider to board
M2 - Mon Aug 04, 5:01AM CDT
Science and engineering company DuPont (NYSE
DD: 76.18 (-0.11)
Mark Schneider Elected to DuPont Board of Directors
PR Newswire - Fri Aug 01, 3:01PM CDT
DuPont today announced the election of Ulf M. "Mark" Schneider, President and CEO of Fresenius SE & Co. KGaA to its board of directors, effective Oct. 22.
DD: 76.18 (-0.11)